“WaterTok” Has Become The Most Controversial Food Trend Of 2023

Water nausea, as it turns out, is actually a lesser-understood phenomenon, so I spoke with Dr. Supriya Rao — who is quadruple board-certified in internal medicine, gastroenterology, obesity medicine, and lifestyle medicine — to further explain these experiences. As Rao puts it, there are several reasons why one could experience nausea after drinking water, and…

Edwards Lifesciences cooperating with EU antitrust regulators 

Health 27 September 2023, 2:03 pm 1 minute Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on…

Cigna explores shedding Medicare Advantage business 

DealsGovernmentHealth 06 November 2023, 6:28 pm 1 minute Reuters was first to report that U.S. health insurer Cigna Group (CI.N) is exploring the sale of its Medicare Advantage business, which manages government health insurance for people aged 65 and older, a move that would mark a reversal of its expansion in the sector.   Market Impact…

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

DealsHealth 17 November 2023, 11:31 am 1 minute Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies.  Market…

US FDA finds control lapses at Moderna manufacturing plant 

Health 15 December 2023, 9:42 am 1 minute Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine.  Market Impact Moderna in September said it was in talks with its partners that fill vials and…

ECB sounds out lenders on exposure to Spanish drugmaker Grifols 

Business & FinanceHealth 17 January 2024, 5:59 pm 1 minute Reuters exclusively reported that the European Central Bank was asking banks to detail their exposure to Spanish drugmaker Grifols and a network of companies linked to the founding family, days after the Barcelona-based business was accused of manipulating its financial accounts by a short-seller. The…

Eli Lilly could launch obesity drug in India next year

Health 28 February 2024, 12:55 pm 1 minute Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review.  Market Impact The market opportunity is huge in the world’s most…

End of content

End of content